Friday, September 24, 2021
News

Roche's Evrysdi (risdiplam) - the first and only oral treatment for adults and children two months or older suffering from Spinal Muscular Atrophy (SMA) - now available in India

   SocialTwist Tell-a-Friend    Print this Page   COMMENT

Business | July 29, 2021 6:45:32 PM IST
Mumbai (Maharashtra) [India], July 29 (ANI/PR Newswire): Roche today announced the launch of Evrysdi (risdiplam), the first and only approved treatment in India for Spinal Muscular Atrophy (SMA) patients.

Evrysdi was first approved by the US FDA in August 2020 and is today available in India within 11 months of the US approval. Since its launch, over 4,000 SMA patients across 50+ countries have benefitted from Evrysdi.

This story is provided by PRNewswire. ANI will not be responsible in any way for the content of this article. (ANI/PRNewswire)

 
  LATEST COMMENTS ()
POST YOUR COMMENT
Comments Not Available
 
POST YOUR COMMENT
 
 
TRENDING TOPICS
 
 
CITY NEWS
MORE CITIES
 
 
 
MORE BUSINESS NEWS
D7 Events by Akash Goyal launch In-House...
Airtel selects Tejas Networks for optica...
Record high: Sensex breaches 60K, Nifty ...
Mumbai, Bangalore and London named among...
How Fibre2Fashion B2B wholesale is succe...
UltraTech Cement joins RE100, commits to...
More...
 
INDIA WORLD ASIA
Mukhtar Ansari says he may be poisoned i...
India administers 84 cr COVID-19 vaccine...
India reports 31,382 new COVID-19 cases...
Manipur CM inaugurates various developme...
India administers over 84 cr COVID-19 va...
Himachal: 10 die due to heavy rain in pa...
More...    
 
 Top Stories
Ajeenkya DY Patil University (ADYPU... 
Kristen Stewart nails Princess Dian... 
Exela Technologies expands electron... 
Bag from Alwar adds new angle to Ma... 
'Afghanistan wants friendly ties wi... 
Punjab CM gets Rahul's nod for cabi... 
Kamal Haasan asks party cadre to pa... 
SL FM briefs Indian counterpart on ...